metoprolol has been researched along with Asymmetric Septal Hypertrophy, Familial in 2 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X | 1 |
| Jiang, J | 1 |
| Zhu, W | 1 |
| Wu, Y | 1 |
| Su, M | 1 |
| Bratt, EL | 1 |
| Östman-Smith, I | 1 |
2 other studies available for metoprolol and Asymmetric Septal Hypertrophy, Familial
| Article | Year |
|---|---|
Next-generation sequencing (NGS) as a molecular diagnostic tool for hypertrophic cardiomyopathy in a Chinese boy due to novel compound heterozygous mutations in the MYBPC3 gene: A case report.
Topics: Adrenergic beta-1 Receptor Antagonists; Cardiomyopathy, Hypertrophic, Familial; Carrier Proteins; Ch | 2019 |
Effects of lifestyle changes and high-dose β-blocker therapy on exercise capacity in children, adolescents, and young adults with hypertrophic cardiomyopathy.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aging; Blood Pressure; Cardiomyopathy, Hypertrophic, | 2015 |